Results 1-20 of 217 for drugs speaker:Richard Boyd Barrett

Ceisteanna - Questions: Taoiseach's Meetings and Engagements (5 Mar 2019)

Richard Boyd Barrett: Did the Taoiseach discuss with the Portuguese Prime Minister Portugal's model for dealing with illicit drugs? There are major parallels, historically and socially, between Portugal and Ireland in the sense that Portugal developed a big problem with illicit drugs at a similar time to this country in the 1980s. It was an enormous problem, with high rates of HIV, drug related crime, addiction...

Written Answers — Department of Health: Misuse of Drugs (12 Jul 2016)

Richard Boyd Barrett: 68. To ask the Minister for Health if there is evidence available that the rescheduling of b​enzodiazepines or ​Z​ drugs could​ prevent the misuse of dangerous or harmful drugs; the specific requests the Garda made to him regarding the rescheduling of these drugs; and if he will make a statement on the matter. [20705/16]

Written Answers — Department of Health: Medicinal Products Prices (27 Oct 2016)

Richard Boyd Barrett: 130. To ask the Minister for Health the action he is taking to address the delay in negotiating a price for the life-saving drug Orkambi; if he will put a cap on the price of newly released drugs in the national interest; the strategy the Government is taking to deal with the issue of overcharging for medication here in general, and for newly released drugs for specific conditions in...

Written Answers — Department of Finance: VAT Exemptions (11 Dec 2018)

Richard Boyd Barrett: 136. To ask the Minister for Finance if the drugs Nivolumab and Pembrolizumab will be made VAT exempt and tax allowable in circumstances in which a patient has no option but to self-fund these drugs; and if he will make a statement on the matter. [51695/18]

Written Answers — Department of Health: Drugs Payment Scheme (10 Mar 2021)

Richard Boyd Barrett: 777. To ask the Minister for Health the reason the drug semaglutide has been removed from the drugs payment scheme for use by polycystic ovary syndrome patients; his plans to reinstate it; and if he will make a statement on the matter. [12672/21]

Written Answers — Department of Health: Drugs Payment Scheme (10 Mar 2021)

Richard Boyd Barrett: 778. To ask the Minister for Health the reason semaglutide has been removed from the drugs payment scheme for use by polycystic ovary syndrome patients; if he plans to reinstate the drug on the scheme; and if he will make a statement on the matter. [12674/21]

Written Answers — Department of Health: Drugs Payment Scheme (10 Mar 2021)

Richard Boyd Barrett: 779. To ask the Minister for Health if drugs for the treatment of hyperemesis gravidarum are being considered for the drugs payment scheme or medical card; and if he will make a statement on the matter. [12677/21]

Written Answers — Department of Health: Drug Treatment Programmes Funding (15 Dec 2015)

Richard Boyd Barrett: 416. To ask the Minister for Health the obligations the successful tender applicants must meet in respect of funding from the Dún Laoghaire-Rathdown Drug and Alcohol Task Force for the provision of drug and alcohol addiction services; and if he will make a statement on the matter. [44943/15]

Written Answers — Department of Health: Cystic Fibrosis Treatment (15 Dec 2015)

Richard Boyd Barrett: 469. To ask the Minister for Health given the reports of the cost of the new Cystic Fibrosis drug, if he will provide comparatives of costs for other drugs used across his Department and the Health Service Executive; and if he will make a statement on the matter. [45316/15]

Adjournment Debate: Medicinal Products Availability (2 Jun 2016)

Richard Boyd Barrett: ...is aware that in the past few weeks, we have had two instances where people who are ill, often with life-threatening illnesses or seriously disabling illnesses, are not able to access certain drugs because of price, rather than the question of their medical efficacy or how they could help people who are sick, suffering or, in some cases, in life-threatening situations. That is just not...

Misuse of Drugs (Amendment) Bill 2016: Second Stage (Resumed) (7 Jul 2016)

Richard Boyd Barrett: ...failed policy approach that has brought us to the fairly sorry pass we are now at. In a way, it is also the worst sort of opportunism in that it plays politics with deadly serious issues such as drug addiction and gangland crime. The bizarre response to that can only really be explained by knee-jerk political opportunism, combined with a complete failure to understand the flaws in the...

Written Answers — Department of Health: Medicinal Products Expenditure (13 Jan 2016)

Richard Boyd Barrett: 666. To ask the Minister for Health the amount the Health Service Executive and his Department spent on the drug Ritaline and on all psychoactive medication used by children, by generic drug and brand name in each year of the past ten years; and if he will make a statement on the matter. [1270/16]

Written Answers — Department of Health: Mental Health Services (6 Oct 2015)

Richard Boyd Barrett: 587. To ask the Minister for Health given recently expressed concern regarding inappropriate prescribing of psychotropic drugs to older or disabled patients, the arrangements his Department has put in place to monitor the appropriateness of the rapidly increasing prescription of psychotropic drugs for children; and if he will make a statement on the matter. [34652/15]

Ceisteanna (Atógáil) - Questions (Resumed): Cabinet Committee Meetings (3 Jul 2019)

Richard Boyd Barrett: ...inequity in the cancer treatment available to people with malignant melanoma. Some people who have the right private health insurance can get access to pembro and other potentially life saving drugs, while others who do not have private health insurance or have the wrong policy cannot. It is shameful that money should dictate access to cancer care which could be potentially life saving....

Written Answers — Department of Health: Health Products Regulatory Authority (6 Dec 2016)

Richard Boyd Barrett: ...to raise concerns or make complaints regarding beliefs concerning widespread malpractice and policy failure in the health service, in the area of medical research and the trial use of certain drugs, or similar medical or drug related research undertaken by other areas in the public service such as the education sector; and if he will make a statement on the matter. [38433/16]

Written Answers — Department of Health: Medicinal Products Reimbursement (10 Jul 2018)

Richard Boyd Barrett: 537. To ask the Minister for Health if the approval of the drugs Nivolumab and Pembrolizumab will be expedited in order to prolong the life of certain cancer patients and in particular in the case of a person (details supplied); if they will be made VAT exempt and tax allowable in the circumstances in which a patient has no option but to self fund these drugs; and if he will make a statement...

Written Answers — Department of Health: Medicinal Products Data (22 Nov 2016)

Richard Boyd Barrett: 431. To ask the Minister for Health if, in view of the National Centre for Pharmaco-Economics report that the drug Orkambi prolongs life by a median 7.4 years, 2.45 QALY and the cost-effectiveness threshold of €30,000 per annum, if he will advise of the average cost and lowest cost per annum charged for the drug in the EU; if the HSE will make an offer to the manufacturer in view of...

Joint Oireachtas Committee on Housing, Planning and Local Government: Reports on Homelessness: Discussion (8 Nov 2018)

Richard Boyd Barrett: ...in the area from where they live close to their family members and on and that they would not have to traipse all the way into town. It is particularly self-evident in cases where that person does not have a drug habit or is recovering from a drug or alcohol problem. However, that person is being told they cannot self-accommodate in Dún Laoghaire, even though they can find a place,...

Misuse of Drugs (Cannabis Regulation) Bill 2022: Second Stage [Private Members] (31 Jan 2024)

Richard Boyd Barrett: ...is especially the case given the citizens' assembly has made the recommendations. On the wider issue, we are clear about this and straight up. We believe in the legalisation and regulation of drugs because we think criminalisation has failed disastrously. It has done far more damage to our society than would legalising and regulating drugs properly, and it is doing it every day. It...

Ceisteanna ar Reachtaíocht a Gealladh - Questions on Promised Legislation (3 Jul 2019)

Richard Boyd Barrett: ...two-tier health system. However, Professor John Crown highlighted recently the shocking situation where people with cancer, specifically stage III melanoma, cannot get the optimum healthcare - the drug pembrolizumab - and other potentially life-saving drugs because they do not have private health insurance, or do not have a particular form of private health insurance. In the last week, I...